Tarsus Pharmaceuticals, Inc.TARSNASDAQ
Loading
Revenue ScalingExpanding
Percentile Rank100
3Y CAGR+159.5%
Studio
Year-over-Year Change

Total revenue from sales of goods and services

3Y CAGR
+159.5%/yr
Annual compound
Percentile
P100
Near historical high
vs 3Y Ago
17.5x
Strong expansion
Streak
2 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$451.36M+146.7%
2024$182.95M+948.6%
2023$17.45M-32.4%
2022$25.82M-54.7%
2021$57.03M-
2020$0.00-
2019$0.00-
2018$0.00-